Applications · Cosmetic & personal care actives
Novel peptide actives with a defined target and real binding data.
The next generation of evidence-based skincare will not come from accidental finds. It will be designed against a defined target protein, with measured binding affinity, and a characterized mechanism of action. The world's largest ingredient houses are already investing in AI-designed peptides. Lagomics builds that molecule and the data to evaluate it.
What you get: a novel peptide sequence designed from scratch, binding data against the target protein (KD), functional activity (IC50), biophysical characterization (solubility, thermal and pH stability), an in-silico safety check, and a recommended working concentration for formulation guidance.
How a partnership works: We design the molecule. You formulate the product. Lagomics delivers a characterized candidate. The ingredient house or brand handles formulation, stability testing, human studies, and go-to-market. IP can be structured as licensing, co-development, or design-on-demand.
Tell us what target you're working toward.